Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ATXN2 | Q99700 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20954377 | 0.84 | CYP1A2 (0.41) | L3MBTL1HTTMAPTSMN1; SMN2POLB | |
| SCHEMBL3645146 | 0.83 | L3MBTL1 (0.42) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL10682408 | 0.83 | TACR1 (0.38) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL28687511 | 0.83 | KDM4E (0.49) | L3MBTL1HTTMAPTSMN1; SMN2POLB | |
| SCHEMBL2167806 | 0.82 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1SMN1; SMN2POLBKDM4E | |
| SCHEMBL22364183 | 0.82 | KDM4E (0.41) | L3MBTL1HTTMAPTSMN1; SMN2POLB | |
| SCHEMBL3705785 | 0.82 | CYP1A2 (0.44) | L3MBTL1HTTMAPTSMN1; SMN2POLB | |
| SCHEMBL27828819 | 0.82 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| SCHEMBL26850220 | 0.81 | POLB (0.44) | ALDH1A1L3MBTL1HTTMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1532536 | 0.81 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1SMN1; SMN2POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4073062-B1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | RYVU THERAPEUTICS S A (PL) | 2026-04-29 | — | — | EP | disclosed |
| US-20230076506-A1 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2023-03-09 | — | — | US | disclosed |
| US-20230055741-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2023-02-23 | — | — | US | disclosed |
| EP-4073063-A1 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-10-19 | — | — | EP | disclosed |
| EP-4073062-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-10-19 | — | — | EP | disclosed |
| WO-2021116446-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021116446-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021116451-A1 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021116451-A1 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2021-06-17 | — | — | WO | disclosed |
| CN-106674096-A | Synthesis method of 2, 3-bis-substituted pyridine derivative | 上海键合医药科技有限公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-102164894-A | Heteroaryl antagonists of prostaglandin D2 receptors | AMIRA PHARMACEUTICALS INC | 2011-08-24 | — | — | CN | disclosed |
| EP-1263731-B1 | METHOD FOR PRODUCING 5-ARYL NICOTINALDEHYDES | MERCK PATENT GMBH (DE) | 2010-08-11 | — | — | EP | disclosed |
| US-RE41008-E1 | catalytic hydrogenation 5-arylnicotinic acids in presence of a palladium/ligand complex; intermediates for making N-alkylated amine; for crop protection, such as, fungicides, insecticides, herbicides or pesticides and drugs | MERCK PATENT GMBH (DE) | 2009-11-24 | — | — | US | disclosed |
| CN-101291908-A | Immunosuppressant compounds and compositions | IRM LLC (BM) | 2008-10-22 | — | — | CN | disclosed |
| US-6703509-B2 | REDUCTION OF 5-ARYLNICOTINIC ACIDS BY CATALYTIC HYDROGENATION IN THE PRESENCE OF CARBOXYLIC ANHYDRIDES IN WHICH THE CATALYST USED IS A PALLADIUM/LIGAND COMPLEX TO PRODUCE ARYINICOTINALDEHYDES | MERCK PATENT GMBH (DE) | 2004-03-09 | — | — | US | disclosed |
| US-20030055259-A1 | Method for producing 5-aryl nicotinaldehydes | MERCK PATENT GMBH (DE) | 2003-03-20 | — | — | US | disclosed |
| EP-1263731-A1 | METHOD FOR PRODUCING 5-ARYL NICOTINALDEHYDES | MERCK PATENT GmbH (DE) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001058873-A1 | METHOD FOR PRODUCING 5-ARYL NICOTINALDEHYDES | MERCK PATENT GMBH (DE) | 2001-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055259-A1 | Method for producing 5-aryl nicotinaldehydes | NAPRT, NOX5, NNT | ALDH1A1 101/4885L3MBTL1 4797/4885HTT 1316/4885 |
| US-20230055741-A1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | STING1, IRF3, CGAS | ALDH1A1 3577/4885L3MBTL1 4263/4885HTT 4797/4885 |
| US-20230076506-A1 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | STING1, IRF3, CGAS | ALDH1A1 4263/4885L3MBTL1 4736/4885HTT 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.